Belzutifan

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 230 publications

Hypoxia-responsive interaction between P-TEFb, BHLHE40, and Tim8-Tim13 regulates hypoxic gene transcription.

Hypoxia-responsive interaction between P-TEFb, BHLHE40, and Tim8-Tim13 regulates hypoxic gene transcription.

Journal: Science advances

Published: May 20, 2026

Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions.

Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions.

Journal: Cureus

Published: May 16, 2026

Von Hippel-Lindau disease: pathophysiological and clinical advances.

Von Hippel-Lindau disease: pathophysiological and clinical advances.

Journal: Familial cancer

Published: April 18, 2026

From prevention to progression: can belzutifan-based strategies deliver across the RCC disease continuum?

From prevention to progression: can belzutifan-based strategies deliver across the RCC disease continuum?

Journal: The oncologist

Published: March 31, 2026

The clinical landscape of HIF2α inhibitors in oncology.

The clinical landscape of HIF2α inhibitors in oncology.

Journal: Nature reviews. Clinical oncology

Published: March 23, 2026

HIF-2α Inhibitor Combinations Knock Back Kidney Cancer in Two Trials.

HIF-2α Inhibitor Combinations Knock Back Kidney Cancer in Two Trials.

Journal: Cancer discovery

Published: March 10, 2026

HIF inhibition: Current strategies and clinical challenges.

HIF inhibition: Current strategies and clinical challenges.

Journal: Redox biology

Published: March 09, 2026

Belzutifan for Metastatic TFE3-Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report.

Belzutifan for Metastatic TFE3-Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report.

Journal: IJU case reports

Published: February 28, 2026

Sporadic retinal capillary hemangioma regresses with belzutifan.

Sporadic retinal capillary hemangioma regresses with belzutifan.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: February 17, 2026

Degradation-Controlled Synchronization of HIF-2α and MEK Inhibition Using Self-Sealed Porous Silicon Nanoparticles to Reprogram Tumor Immunogenicity.

Degradation-Controlled Synchronization of HIF-2α and MEK Inhibition Using Self-Sealed Porous Silicon Nanoparticles to Reprogram Tumor Immunogenicity.

Journal: Acta biomaterialia

Published: February 14, 2026

Belzutifan for Advanced Pheochromocytoma or Paraganglioma.

Belzutifan for Advanced Pheochromocytoma or Paraganglioma.

Journal: The New England journal of medicine

Published: February 11, 2026

Belzutifan for Advanced Pheochromocytoma or Paraganglioma. Reply.

Belzutifan for Advanced Pheochromocytoma or Paraganglioma. Reply.

Journal: The New England journal of medicine

Published: February 11, 2026

Showing 1-12 of 230

Last Updated: 06/30/2026